Athletes subject to WADA, USADA, NCAA, or any sport-governing-body testing should not use AOD-9604 in any form
The dashes (--) indicate doses that would exceed a standard 100-unit insulin syringe capacity at that concentration
Key Takeaways CJC-1295 is a GHRH analog: It binds to GHRH receptors in the pituitary to stimulate growth hormone release Ipamorelin is a GHRP (ghrelin mimetic): It binds to GHS-R1a receptors via a completely different pathway Different mechanisms make them complementary: Published research often examines their combination due to non-competing receptor targets Neither is FDA-approved: Both remain research compounds not intended for human therapeutic use Combination protocols appear in published literature: Studies by Bowers et al
These approaches aim to accelerate healing, reduce complications, enhance patient comfort, and improve overall outcomes in the management of acute and chronic wounds
Mistake 6: storing all supply as reconstituted solution Some researchers reconstitute their entire supply at once for convenience
[4] These are the documented risks of a regulated, native IGF-1 product administered under medical supervision
